Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumes:
Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v9.i1.20
pages 7-14

Evaluation of Therapeutic Activity of Hypogeous Ascomycetes and Basidiomycetes from North America

Rita Stanikunaite
Department of Pharmacognosy, The University of Mississippi, University, MS, USA
James M. Trappe
Department of Forest Service, Oregon State University, Corvallis, Oregon 97331-5257, USA
Shabana I. Khan
National Center for Natural Products Research, The University of Mississippi, University, MS, USA
Samir A. Ross
Department of Pharmacognosy and National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, Mississippi 38677

SINOPSIS

This study is the first broad investigation of therapeutic activities of hypogeous truffles and truffle-like fungi (Ascomycetes and Basidiomycetes) from North America. Twenty-two species from 12 families were evaluated in several biological assays for antimicrobial, antimalarial, antiinflammatory, antioxidant, antituberculosis, and anticancer activities. Biological screening results indicate that 1 species showed antimalarial activity, 11 species were active in antioxidant assay, 9 species were active in antiinflammatory assay, 9 species showed antituberculosis activity, and 2 species showed anticancer activity. Among the screened species, Elaphomyces granulatus, E. muricatus, Geopora clausa, Hymenogaster subalpinus, Melanogaster tuberiformis, Rhizopogon couchii, R. nigrescens, R. pedicellus, R. subaustralis, R. subgelatinosus, and Scleroderma laeve expressed therapeutic activity in more than one assay. Our results indicate that this group of fungi has promising therapeutic activities that could lead to the development of new agents for the treatment and prevention of diseases.


Articles with similar content:

Antiproliferative and Antioxidant Activities of Wild Boletales Mushrooms from France
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 1
Caroline Guzman, Patrick Poucheret, Manon Vitou, Stéphanie Arnould, Frédéric Boudard, Sylvie Rapior, Sylvie Morel, Françoise Fons
Antibacterial Activity of Mediterranean Oyster Mushrooms, Species of Genus Pleurotus (Higher Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 6
Vincenzo Arizza, Maria Letizia Gargano, Domenico Schillaci, Giuseppe Venturella
Medicinal Mushrooms: A New Source for Breast Cancer Therapeutics
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Roumyana D. Petrova, Cvetomir M. Denchev, Jamal A. Mahajna
Novel Antibacterial Compounds Obtained from Some Edible Mushrooms
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Karuppaiya Periasamy
Isolation and Characterization of Bioactive Metabolites from Fruiting Bodies and Mycelial Culture of Ganoderma oerstedii (Higher Basidiomycetes) from Mexico
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 6
Jorge Suarez-Medellin, Cesar Espinoza, Manuel Norte, Angel Ramos-Ligonio, Jose J. Fernandez, Ángel Trigos, Guillermo Mendoza